THE U.S. CENTRAL VENOUS CATHETER MARKET IS ANTICIPATED TO WITNESS HIGH GROWTH OWING TO INCREASING NEED FOR LONG-TERM IV THERAPY THE U.S. CENTRAL VENOUS CATHETER MARKET IS ANTICIPATED TO WITNESS HIGH GROWTH OWING TO INCREASING NEED FOR LONG-TERM IV THERAPY

The U.S. Central Venous Catheter Market is Anticipated to Witness High Growth Owing to Increasing Need For Long-Term IV Therapy The U.S. Central Venous Catheter Market is Anticipated to Witness High Growth Owing to Increasing Need For Long-Term IV Therapy

The U.S. Central Venous Catheter Market is Anticipated to Witness High Growth Owing to Increasing Need For Long-Term IV Therapy The U.S. Central Venous Catheter Market is Anticipated to Witness High Growth Owing to Increasing Need For Long-Term IV Therapy

Blog Article

The U.S. central venous catheter market offers long term central access to the central circulation for purposes like chemotherapy, parenteral nutrition, blood sampling, and long term antibiotic therapy. Central venous catheters are medical devices that are inserted into a large vein in the neck, chest, or groin to administer medications or fluids, obtain blood samples, and facilitate measurements of central venous pressure. The increasing prevalence of chronic diseases like cancer requiring long term medical treatment and intensive care has boosted the demand for central venous catheters. The market is estimated to be valued at US$ 1,142.4 Mn in 2024 and is expected to exhibit a CAGR of 6.2% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the U.S. central venous catheter are Robert Bosch GmbH., Continental AG, DENSO CORPORATION, HELLA GmbH & Co. KGaA, Infineon Technologies AG, Autoliv Inc., Lockheed Martin Corporation., NXP Semiconductors., smart microwave sensors GmbH, Oculii Corporation, SRC, Inc., Arbe, Echodyne Corp., Raytheon Company Corporation, Saab AB, Northrop Grumman, ZF Friedrichshafen AG, Hitachi, Ltd., InnoSenT - Innovative Radar Sensor Technology, and Kestrel Radar Sensors among others. The North America region accounts for the largest market share currently and is expected to continue dominating the market during the forecast period.

Key opportunities in the U.S. central venous catheter market Growth include development of advanced catheters integrated with safety features and remote data monitoring capabilities. Companies are investing in R&D to develop novel catheter designs for difficult insertion sites like femoral veins which can reduce complication risks. The increasing prevalence of chronic diseases globally is also prompting market players to expand their product offerings and distribution networks across international markets in Asia Pacific and Middle East & Africa.

Market Drivers and Restrain

Market drivers - The increasing prevalence of chronic diseases requiring long term IV therapy like cancer, diabetes and gastrointestinal diseases is a major factor driving the demand for central venous catheters. Growing geriatric population also increases the risk of age-related diseases augmenting the need for catheters.

Market restraints –

However, risks of catheter-related bloodstream infections and complications during insertion limit the complete market potential. Lack of skilled surgeons and interventional radiologists for proper catheter placement in developing regions also acts as a challenge. Regulatory issues related to new product approval further delays product launches.

Segment Analysis
The central venous catheter market is segmented into peripherally inserted central catheters (PICC), tunneled catheters, nontunneled catheters, and implanted ports. Among these, the PICC segment is dominating the market. This is mainly because PICCS are more flexible and comfortable for patients as they have smaller diameters. They are also adjustable and removable which makes them a preferred option among medical professionals for both short- and long-term usage.

Global Analysis
Regionally, North America is holding the largest share in US Central Venous Catheter Market Regional Analysis and is expected to dominate during the forecast period. This is majorly due to the advanced healthcare infrastructure and higher access to better treatment options in the region. Moreover, the growing geriatric population who are more prone to chronic diseases along with the increasing number of surgical procedures are augmenting the market growth in North America. On the other hand, Asia Pacific is projected to witness the fastest growth during forecast period owing to increasing healthcare expenditure, rising medical tourism, and growing demand for advanced treatment options from large patient pool in the region. The growing number of hospitals and improving reimbursement scenario is also contributing to the market growth of central venous catheter in Asia Pacific.

Get More Insights On  U.S. Central Venous Catheter Market
Explore More Related Articles- Lactulose Market

 

 

For Deeper Insights, Find the Report in the Language that You want.


 

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

Report this page